We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+15.6%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$8.4B
AUM Growth
+$1.66B
Cap. Flow
+$1.33B
Cap. Flow %
15.85%
Top 10 Hldgs %
61.33%
Holding
510
New
182
Increased
113
Reduced
52
Closed
146

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$79.7M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$74.4M
3
KVUE icon
Kenvue
KVUE
+$65.3M
4
ELF icon
e.l.f. Beauty
ELF
+$51.7M
5
GSK icon
GSK
GSK
+$46.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$96.3M
2
EXAS
Exact Sciences
EXAS
+$56.4M
3
PTCT icon
PTC Therapeutics
PTCT
+$34.5M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$28M
5
MDB icon
MongoDB
MDB
+$23M

Sector Composition

Rank Sector Weight
1 Healthcare 32.56%
2 Technology 5.44%
3 Consumer Discretionary 5.13%
4 Consumer Staples 2.69%
5 Communication Services 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHW icon
201
Sherwin-Williams
SHW
$89.7B
$667K 0.01%
2,058
-434
-17% -$145K
HHH icon
202
Howard Hughes
HHH
$3.92B
$640K 0.01%
+8,023
New +$665K
ED icon
203
Consolidated Edison
ED
$39.9B
$630K 0.01%
6,340
-3,171
-33% -$315K
WMG icon
204
Warner Music
WMG
$13.6B
$610K 0.01%
+19,903
New +$608K
OXY icon
205
Occidental Petroleum
OXY
$53.5B
$575K 0.01%
+13,976
New +$583K
LIVN icon
206
LivaNova
LIVN
$4.29B
$574K 0.01%
9,325
+5,075
+119% +$290K
DAY
207
DELISTED
Dayforce
DAY
$571K 0.01%
8,250
-105
-1% -$7.23K
ADIL
208
Adial Pharmaceuticals
ADIL
$8.86M
$562K 0.01%
+102,178
New +$827K
RSG icon
209
Republic Services
RSG
$63.7B
$549K 0.01%
2,592
+1,286
+98% +$277K
ALC icon
210
Alcon
ALC
$34.4B
$521K 0.01%
+6,615
New +$509K
AAL icon
211
American Airlines Group
AAL
$11B
$498K 0.01%
+32,507
New +$439K
ADGM
212
Adagio Medical Holdings
ADGM
$16.4M
$497K 0.01%
+478,000
New +$567K
ALK icon
213
Alaska Air
ALK
$5.81B
$495K 0.01%
+9,834
New +$455K
ITW icon
214
Illinois Tool Works
ITW
$85.5B
$491K 0.01%
+1,994
New +$497K
MTD icon
215
Mettler-Toledo International
MTD
$28.5B
$474K 0.01%
340
+93
+38% +$130K
ANY icon
216
Sphere 3D
ANY
$17.4M
$465K 0.01%
+156,207
New +$936K
ABCB icon
217
Ameris Bancorp
ABCB
$5.97B
$464K 0.01%
+6,246
New +$465K
ETSY icon
218
Etsy
ETSY
$8.15B
$443K 0.01%
+7,989
New +$488K
WLDS icon
219
Wearable Devices
WLDS
$6.33M
$429K 0.01%
+41,800
New +$905K
MMSI icon
220
Merit Medical Systems
MMSI
$5.21B
$423K 0.01%
+4,796
New +$408K
MSCI icon
221
MSCI
MSCI
$41.6B
$419K 0.01%
+731
New +$410K
PCTY icon
222
Paylocity
PCTY
$7.91B
$415K ﹤0.01%
2,719
-751
-22% -$112K
ZS icon
223
Zscaler
ZS
$26.1B
$410K ﹤0.01%
+1,822
New +$514K
ECL icon
224
Ecolab
ECL
$80.3B
$410K ﹤0.01%
1,561
+656
+72% +$175K
CYBR
225
DELISTED
CyberArk
CYBR
$405K ﹤0.01%
+908
New +$437K
7 8
9
10 11

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Armistice Capital held 510 positions worth $8.4B, up 25% from $6.74B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Armistice Capital deployed $1.33B of net new capital in Q4 2025, opening 182 new positions and adding to 113 existing holdings. Its largest new stake was Kenvue: 3,992,196 shares worth $68.9M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Travere Therapeutics, an estimated $96.3M trimmed.

  • Armistice Capital's largest Q4 2025 buy was Kenvue: 3,992,196 shares worth $68.9M.
  • Armistice Capital added most to Agios Pharmaceuticals in Q4 2025, an estimated $79.7M increase.
  • Armistice Capital's biggest Q4 2025 reduction was Travere Therapeutics, cutting an estimated $96.3M.
  • Armistice Capital fully exited Exact Sciences in Q4 2025, selling an estimated $56.4M.
  • Armistice Capital's ten largest holdings make up 61% of its $8.4B portfolio in Q4 2025.
  • Armistice Capital opened 182 new positions and closed 146 in Q4 2025.
  • Armistice Capital's portfolio value rose 25% quarter-over-quarter to $8.4B.

Based on Armistice Capital's 13F filing for Q4 2025, filed 17 Feb 2026.